Status:
TERMINATED
Lung Cancer Case Registry and Tissue Resource
Lead Sponsor:
University of New Mexico
Conditions:
Lung Cancer
Eligibility:
All Genders
Brief Summary
Potential participants in the Lung Cancer Case Registry will be all patients diagnosed or evaluated for possible treatment of lung cancer at the Cancer Research and Treatment Center (CRTC) and New Mex...
Detailed Description
Lung cancer is the most common cause of cancer death in the US in both men and women. This research study will enroll lung cancer patients into a registry to study changes in DNA (or genetic material)...
Eligibility Criteria
Inclusion
- Potential participants in the Lung Cancer Case Registry will be all patients diagnosed or evaluated for possible treatment of lung cancer at the CRTC and NMVHCS. Recruiting will primarily be performed through the Multidisciplinary Chest Clinics held weekly at each hospital. These clinics are staffed by the Principal Investigator (PI) and Reza Mehran, MD, a thoracic surgeon at both hospitals and a co-investigator on this submission. Approximately 90% of all lung cancer cases diagnosed at the NMVHCS, and a somewhat smaller proportion of cases treated in the Cancer Center, are seen in these clinics. Additional cases will be identified through review of new patient visits to each hospital with a diagnosis of lung cancer; Drs. Crowell and Mehran also maintain weekly contact with pathology and oncology services at both facilities, which will facilitate case identification at NMVHCS and University Hospital. Finally, patient contact records will be correlated with tumor registry records at both hospitals, which will identify any cases not captured through the above mechanisms. Although these cases may be identified several weeks after initial diagnosis, all attempts will still be made to contact the patient and family for enrollment into the registry. Most Spanish-speaking patients served by the CRTC and the NMVHCS are bilingual, and a language barrier has not been a problem in other similar studies conducted by the PI. However, Spanish-speaking personnel are available to obtain consent and answer any questions if necessary.
Exclusion
- Patients will be excluded if they cannot provide written informed consent.
Key Trial Info
Start Date :
March 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2016
Estimated Enrollment :
750 Patients enrolled
Trial Details
Trial ID
NCT00250848
Start Date
March 1 2004
End Date
June 1 2016
Last Update
January 8 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of New Mexico Cancer Center
Albuquerque, New Mexico, United States, 87106
2
New Mexico Veterans Administration Health Care System
Albuquerque, New Mexico, United States, 87108